Cessatech Investor Relations Material
Latest events
Q1 2025
15 May, 2025
Q4 2024
28 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cessatech
Access all reports
Cessatech is a biopharmaceutical company developing non-invasive treatments for pain management, particularly in pediatric patients. It focuses on innovative anesthetic and analgesic formulations. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CESSA
Country
🇩🇰 Denmark